C. Kremer

Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2018, The Journal of Nuclear Medicine.

Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2018, The Journal of Nuclear Medicine.

Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT

B. Hadaschik, U. Haberkorn, F. Giesel, 2018, The Journal of Nuclear Medicine.

[18F]PSMA‐1007 PET Improves the Diagnosis of Local Recurrence and Lymph Node Metastases in a Prostate Cancer Patient With a History of Bilateral Hip Arthroplasty

U. Haberkorn, F. Giesel, C. Kratochwil, 2018, Clinical genitourinary cancer.

[Significance and Value of PSMA Ligands in Prostate Cancer].

B. Hadaschik, U. Haberkorn, F. Giesel, 2017, Aktuelle Urologie.

68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients

T. Holland-Letz, J. Debus, K. Herfarth, 2018, The Journal of Nuclear Medicine.

Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients

H. Kauczor, U. Haberkorn, F. Giesel, 2017, Cancer Imaging.

Intra-individual comparison of Tc-99m-MDP bone scan and the PSMA-ligand Tc-99m-MIP-1427 in patients with osseous metastasized prostate cancer

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2018 .